©2024 Stanford Medicine
A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma
Recruiting
I'm InterestedTrial ID: NCT03941379
Purpose
The purpose of this observational research study is to follow participants who have been
treated with either bel-sar or received alternate treatment (sham, standard of care therapy,
etc.) while participating in a previous Aura Biosciences clinical research study to assess
the long-term safety and effectiveness in these subjects. This study will collect information
from procedures conducted as part of routine follow-up eye care and cancer care.
Additionally, the registry will collect all adverse events, information about pregnancy and
symptomatic overdose.
Official Title
A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma
Stanford Investigator(s)
Prithvi Mruthyunjaya, MD, MHS
Professor of Ophthalmology and, by courtesy, of Radiation Oncology
Eligibility
Inclusion Criteria:
- Have been clinically diagnosed with primary IL or CM at the time of entry to a
previous Aura Biosciences sponsored clinical trial.
- Have received AU-011 bel-sar or assigned to a different cohort or treatment arm (sham,
SoC, etc.) an observation cohort in a previous Aura sponsored clinical trial.
Exclusion Criteria:
- None
Recruiting
I'm InterestedContact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Mariana Nunez
mnunez1@stanford.edu